# Cytovance Biologics Inc. – FDA Inspection, Jun 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/56631e33-d2ff-4f1a-bdb8-d7a325ef8bd9
Source feed: FDA_Inspections

> FDA inspection 1322570 of Cytovance Biologics Inc., June 17, 2026. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322570
- Company Name: Cytovance Biologics Inc.
- Inspection Date: 2026-06-17
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1089182 - 2019-05-09](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/d6179c1f-7a2a-4cce-9010-40bb23f19661)
- FDA Inspection 1078729 - 2018-04-27
- [FDA Inspection 1026556 - 2017-07-20](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/23b9870b-a1d7-4890-bb6f-c476414d80b4)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/hung-h-do/580f78ba-ed7a-4c10-8f4c-a99d0af7206e)
- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.keypedia.com/companies/cytovance-biologics-inc/a03c370a-5e60-4617-95b1-521a1d305ac2

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9